All vendors

Pharm D Solutions, LLC

ActivePrescription Required
United States
US

FDA Class II Recall D-1327-2019 for lack of assurance of sterility on Ipamorelin Acetate injectable vials; recall terminated following firm closure or full market withdrawal.

Testing and trust

Third-party COA

No

Reported issues

  • Closed (May 2019)

Reported issues describe what our data shows. They are not a legal finding.

Is this your company? Claim this listing to correct your details and connect your store.

Claim listing

For educational and research purposes only. Not medical advice. Always consult a qualified healthcare provider before using any research compound.